Abstract Predictors of in-hospital mortality and need for invasive mechanical ventilation (IMV) in chronic obstructive pulmonary disease (COPD) patients presenting with acute hypercapnic respiratory failure (AHRF) are yet lacking, but warranted in elderly population. Formulating a scoring system may aid prognostication.
Introduction
Life expectancy has significantly increased over the last 30 years with an increasing incidence of age-related and aging-related clinical conditions, in particular chronic obstructive pulmonary disease (COPD) [1] . COPD is a common disease in older adults, affecting 14.2% of elderly individuals [2] . It is responsible for 19.9% of hospitalizations of adults aged 65-75 [3] . The clinical course of patients with acute exacerbations of underlying COPD and hypercapnic respiratory failure has not been fully characterized [4] . However, the reported morality rate for COPD presenting with acute hypercapnic respiratory failure (AHRF) varies between 6% and 24% [4] [5] [6] [7] [8] . These rates increase to 14-57% as ventilatory support becomes inevitable [8] [9] [10] .
Determining the factors predicting poor outcome and need for invasive mechanical ventilation (IMV) are of interest to intensivists, because early identification of patients at high risk is essential, as well as tailoring monitoring, therapy and counseling families [8] .
Many prognostic scoring systems have been created for the prediction of patient outcome. General illness severity scores were developed to be used in mixed groups of ICU patients and their accuracy in subgroups of patients can be questioned [11] . Disease-specific prognostic scoring systems are needed.
Many factors have been identified as predictors of ICU mortality [6] [7] [8] [9] 12] in patients with COPD including age and AHRF. Many studies [12] [13] [14] [15] [16] have demonstrated age to be correlated with mortality among COPD patients receiving IMV. Yet other studies reported that age was not an independent predictor of COPD outcome [10, 17] . AHRF has a significant effect on prognosis in patients with COPD [18, 19] .
Although COPD is a common reason for hospital admission in our elderly population, little has been documented about this problem from Egypt. Especially regarding in-hospital mortality and need for IMV in elderly Egyptian COPD patients presenting with AHRF. There is a need to develop a simple and inexpensive prognostic scoring system for such patients.
Keeping these factors in mind, the present study was designed to prospectively determine predictors of in-hospital mortality and need for IMV in elderly COPD patients presenting with AHRF.
Materials and methods

Study population
This study was carried out in the Geriatric and Respiratory ICU (GICU & RICU) at the Ain Shams University hospital, elderly patients (P60 years) admitted for acute exacerbation of COPD (AECOPD) with AHRF were recruited during the period between June 2011 and June 2012.
The diagnosis of COPD was determined by the premorbid pulmonary function testing when available within 2 years of hospital admission based on Global Initiative for Chronic Obstructive Lung Disease guideline, 2010 [20] . Since COPD patients with AHRF were sustaining severe bronchial obstruction, and their general status did not give permission, physiologic assessment with pulmonary function tests could not be performed in all patients. In the absence of documented airflow obstruction, clinical criteria used were, clinical history with compatible physical findings, and/or evidence of hyperinflation on chest radiograph, interpreted by attending physicians, in support of the diagnosis of COPD, as described in the 1995 statement from the American Thoracic Society [21] . AECOPD was determined by increased dyspnea, sputum volume and/ or purulence, beyond day-to-day variations to the extent that changes in therapy were warranted [22] .
AHRF was defined by arterial blood gas criteria (partial pressure of carbon dioxide: PaCO 2 > 45 mmHg and pH < 7.35) [23] .
The patients with acute respiratory distress syndrome, pulmonary embolism, malignancy, respiratory failure due to reasons other than COPD and COPD without hypercapnia were excluded. Those who died within the first 24 h following admission to the ICU or receiving noninvasive ventilation were also excluded form study.
Data collection
Patients' characteristics were recorded during the first 24 h of ICU admission. These included age, sex, smoking history, dyspnea grade (according to Medical Research Council dyspnea scale) [24] , number of exacerbations in the last year, current exacerbation severity (according to Anthonisen AE-COPD types) [25] , vital data, arrhythmia, urinary output, length of stay (LOS) in hospital and ICU, current and previous IMV occurrence, duration of IMV, Simplified Acute Physiology Scores II (SAPS II), Glasgow Coma Score (GCS), multiple organ failure, co-morbid diseases and physical examination findings on admission.
All necessary laboratory results during the first 24 h of ICU admission were recorded [complete blood count, sodium (mEq/l), potassium (mEq/l), creatinine (mg/dl), blood urea nitrogen (BUN) (mg/dl), bilirubin (mg/dl), glucose (mg/dl), albumin (mg/dl), SGOT (IU/L) and SGPT (IU/ L)]. In addition, microbiological cultures for sputum or endotracheal tube aspirate, chest X-ray, arterial blood gases and electrocardiogram were performed. Patient's in-hospital mortality and survival status upon hospital discharge were documented.
The treatment of COPD applied in ICU is according to the international standard of practice guidelines [20, 22] . Criteria for intubation and weaning used were according to what was previously stated in detail by Pierson, 2004 [26] .
Statistical analysis
All results were collected, tabulated and statically analyzed using appropriate statistical methods. Description of data was expressed in form of mean ± SD for quantitative data or number and frequency for qualitative data. Qualitative data were compared using Chi-square or Fisher's exact when appropriate. Non parametric quantitative data were converted into parametric by log transformation and mean ± SD of the original data was expressed. Quantitative data were compared using two samples t-test. Discriminate analysis was performed to compute equations that could predict mortality and IMV. Receiver operator characteristic (ROC) curve for each predicted equation was done, in the presence of significant area under curve (AUC); best cut-off, sensitivity, specificity, positive predicted value (PPV), and negative predicted value (NPV) were calculated. P-Values less than 0.05 were regarded as a sign of statistical significance. All data analyses were performed using the 16th version of SPSS.
Results
Thirty elderly COPD patients presenting with AHRF who fulfilled the study inclusion criteria were enrolled. The descriptive profile of the study group is presented in Table 1 . The in-hospital morality was 13.3% all of whom died in ICU and had IMV.
Patients' characteristics with regard to mortality end point and IMV are shown in Table 2 . There was a significant difference between survivors and non-survivors regarding the LOS in hospital and duration of IMV. Patients in the non survival group had a longer LOS in hospital and IMV duration. There was a significant difference between IMV and non-IMV patients regarding the severe current exacerbation occurrence, LOS in hospital, duration of IMV, arterial blood pH, bicarbonate and SAPS II scores. Patients on IMV had a more severe current exacerbation, longer LOS in hospital and IMV duration, lower pH and bicarbonate (HCO 3 À ), and higher SAPS II scores (Table 2) .
There was no significant difference between survivors and non-survivors as well as IMV and non-IMV patients regarding different co-morbidities (hypertension, diabetes, heart disease) studied except patients with renal impairment were significantly more in survivor than non-survivor patients (P = 0.01).
There was no significant difference between survivor and non-survivor and IMV and non-IMV patients regarding the studied different laboratory results; except patients with positive IMV had a significant lower glucose level (P = 0.008). The mean blood glucose level was 140 mg/dl and 81 mg/dl in survivor and non-survivor patients respectively (P value = 0.008).
The discriminant analysis (DA) showed that sepsis, pack year smoking, severe current exacerbation, SAPS II and lower pH were significant predictors of IMV and discriminant equation for prediction of IMV was constructed (Table 3) .
ROC curve was plotted for studying the accuracy of the predicted equation in prediction of IMV and result is shown (Fig. 1) . ROC curve showed that the predicted equation has a moderate predictive capability with area under the ROC curve (AUC) of 0.878 with a cut-off of PÀ1.1728 having sensitivity, a Non parametric data were converted into parametric by log transformation and mean ± SD of the original data was expressed.
b Dyspnea grade is according to Medical Research Council (MRC) dyspnea scale [24] . c Current exacerbation severity is according to Anthonisen AECOPD types [25] .
specificity, positive and negative predictive values for predicting the need for IMV of 76%, 92%, 93% and 75%, respectively (Table 4) . ROC curve was plotted for studying the accuracy of SAPS II in prediction of IMV and result is shown in Fig. 2 . ROC curve showed that SAPS II has a moderate predictive capability with area under the ROC curve (AUC) of 0.729 with a cutoff of P31 having sensitivity, specificity, positive and negative predictive values for predicting the need for IMV of 70.6%, 76.9%, 80% and 66.7%, respectively (Table 4) . Pair-wise comparison between AUCs of both predicted equation and SAPS II (using medcalc program) revealed a significant difference P = 0.049; therefore; predicted equation is better than SAPS II in prediction of IMV.
The DA showed that the presence of renal impairment, previous history of hypertension, pneumonia, sepsis and lower glucose level were significant predictors of mortality and discriminant equation for prediction of mortality was constructed (Table 5) .
ROC curve was plotted for studying the accuracy of the predicted equation in the prediction of mortality and result is shown in Fig. 3 . ROC curve showed that the predicted equation has a moderate predictive capability with AUC of 0.942 (P = 0.005) with a cut-off of P11.4388 having sensitivity, specificity, positive and negative predictive values for predicting mortality of 100%, 89%, 57% and 100%, respectively.
Studying the accuracy of SAPS II in prediction of mortality showed no significant results (P = 0.143) in elderly COPD patients presenting with AHRF.
Discussion
This study reveals that the in-hospital morality was 13.3% all of whom died in ICU and had IMV. Renal impairment, previ- Qualitative data were compared using Chi-square or Fisher's exact when appropriate. Quantitative data were compared using independent ttest. a Non parametric data were converted into parametric by log transformation and mean ± SD of the original data was expressed. b Dyspnea grade IV is according to Medical Research Council (MRC) dyspnea scale [24] .
ous history of hypertension, pneumonia, sepsis and lower glucose level were significant predictors of mortality and discriminant equation for the prediction of mortality had 94.2% accuracy, sensitivity, specificity, positive and negative predictive values for predicting death of 100%, 89%, 57% and 100%, respectively. In the current study, the incidence need for IMV was 56.7%. Sepsis, pack year smoking, severe current exacerbation, SAPS II and lower pH were significant predictors of IMV and discriminant equation for prediction of IMV had 87.8% accuracy and having sensitivity, specificity, positive and negative predictive values for predicting need for MV of 76%, 92%, 93% and 75%, respectively.
Previous studies evaluating the mortality for AECOPD have shown a wide range of figures. Low morality rate (13.3%) in the current study was in line with those of other reports [13, 14] . Connors et al. [14] and Fuso et al. [13] reported an in-hospital mortality of 11% and 14.4%, respectively. Higher mortality rates (25.2% and 33.1%) were recorded by Mohan et al. [27] and Ucgun et al. [8] respectively. Weiss and Hudson [23] reviewed 11 studies carried out to study the outcome of patients with exacerbation of COPD and found the combined mortality rate to be 20.3%. Differences in disease severity and diversity of the patient's selection in each study may partly explain the variations in mortality figures [8] . IMV is undoubtedly a lifesaving procedure for patients with acute RF [8] . Reports on incidence need of IMV in patients with exacerbation of COPD is variable ranging between 9.8% and 84% [23, 28] . In the current study, 56.7% of the patients underwent IMV. Comparable incidence need for IMV (57.6%) was reported by Ucgun et al. in similar COPD population presenting with AHRF to Respiratory ICU having a mean age of 65.1 years [8] .
Studies aimed at developing clinical prediction tools to improve predicting mortality in AECOPD at the time of admission are scant and there remains a need for a more objective way of prognosticating patients particularly in elderly COPD and those presenting with respiratory failure. Derived equations have been used previously by some authors [27] as in the current study aiming to provide a useful, simple, easily applicable index for prognostication and risk stratification. However, Mohan et al. study was not specific to hypercapnic COPD patients [27] . The current study identified several predictors of in-hospital mortality (Table 5) . Predictors in other studies such as serum creatinine [27] [28] [29] [30] , sepsis [12, 28, 31] , pneumonia [32, 33] linked to an increased risk of in-hospital mortality in AECOPD (without age or AHRF specifications) were comparable to the present study predictors, but in elderly COPD presenting with AHRF.
The role of pneumonia as the predictor of morality among AECOPD has been previously noted by Lieberman et al. [34] and Restrepo et al. [35] in agreement with the present study, but in nonelderly populations. Lieberman et al. [34] evaluated and compared exacerbations in patients with COPD with and without pneumonia, and found that those with pneumonia had a more severe illness, longer LOS, and higher rates of ICU admission and mortality.
Blood glucose is of emerging importance recently in COPD exacerbations [36] .
It has been previously emphasized that lower glucose levels were associated longer hospitalization and 90-day all-cause mortality in patients with AECOPD [37] . In agreement, lower glucose levels were a predictor of mortality among elderly COPD presenting with AHRF in the present study. Older age can increase the risk of developing lower glucose levels because of the higher rate of comorbidities (e.g. renal failure or malnutrition) and elder hospitalized patients often experience failure of regulatory mechanisms, especially in stress situations, such as reduced release of glucagon and epinephrine in response to hypoglycemia [38] . Several previous studies [38] [39] [40] had confirmed that hypoglycemia was a predictor of inhospital morality in elderly hospitalized patients as in the present study.
Very little is known about the relative impact of arterial hypertension on COPD morality [41] . In one study, hypertension has been previously found to be a predictor of cardiovascular mortality outside hospital in elderly patients with stable COPD [41] . In another study, hypertension was the predictor of mortality within 3 months after hospital discharge in 606 COPD patients that were admitted with exacerbation, and 63.4% of them were hypertensive [42] . In our study, hypertension was the predictor to in-hospital mortality in elderly COPD population presenting with AHRF. Thus, emphasizing the importance of hypertension in relation to COPD mortality particularly in the elderly group. In elderly, the following facts may explain such importance: hypertension represents the main co-morbid condition in elderly [43] , the coexistence of hypertension and old age increases per se the risk of cardiovascular mortality due to long-term exposure to common risk factor [44] , combined presence of COPD and hypertension in elderly seems quite common [44] and elderly COPD with hypertension have a lower use of anti-hypertensive drugs [45] . Furthermore, COPD subjects are frequently treated with drugs such as corticosteroids and B2 stimulating agents that limit the effect of some anti-hypertensive drugs [41] .
Age of patients with COPD has been found to be a predictor of in-hospital mortality by some investigators [12] [13] [14] [15] while alike the present study others reported that age was not a predictor of COPD outcome [10, 17, 29] . Absence of age as a predictor of mortality, while the presence of variables such as renal impairment, hypertension, sepsis or pneumonia as predictors of mortality, reflects the importance of comorbidities associated with age rather than the chronological age alone [46] . The chronological age could be surrogate for factors reflecting complicated disease, but not an independent predictor of disease specific mortality [47] .
In the present study, hypercapnia on admission has not been shown to be a predictor of morality in agreement with other previous studies [12, 13, 32, 48] . However, other studies confirmed that the severity of hypercapnia on admission is more clearly related to long-term mortality [7, 49] ; in which individuals with hypercapnia at admission and discharge had significantly higher 5-year mortality rates than those in whom hypercapnia resolved during their hospital stay [50] .
Although IMV is associated with higher mortality rates, it was not a predictor of in-hospital mortality in the current study. This is also similar to the findings by Seneff et al. [51] and Afessa et al. [12] .
The current study identified several predictors of IMV (Table 3). Finding of pH as a predictor of need of IMV in the present study is in consonance with earlier studies. [4, 28, 52] . Even that one study postulated that patients with pH < 7.26 were almost five times more likely to the need of IMV [28] .
Known effect of both smoking and exacerbation severity on spirometric indices in COPD helps in explaining their role as predictor of IMV [53] . Vitacca et al., found that spirometric indices predict the need for IMV in patients presenting with an exacerbation of COPD [54] .
Elderly patients with severe sepsis and septic shock often require IMV [55] . Sepsis as a predictor of IMV in the current study could be attributed to the significance of IMV in sepsis even without respiratory compromise due to that the respiratory muscles are avid consumers of oxygen and can use up to 50% of circulating oxygen. Intubation and paralysis not only increase available oxygen to vital organs, but can also augment cardiac output for patients with persistent septic shock [56] .
The predicted equation was better than SAPS II alone to predict IMV. This could be attributed to the fact that general illness severity scores like SAPS II are not disease specific tools and that disease-specific prognostic scoring is warranted.
This study has several limitations. The study was done in a relatively small sample in one center with little observed mortality. Thus, a larger series would be able to evaluate the prognostic factors and to relate these to prediction of mortality risk. Unfortunately we did not have the opportunity to follow our patients after hospital discharge.
We concluded that elderly COPD patients presenting with AHRF are at risk for in-hospital morality. Renal impairment, previous history of hypertension, pneumonia, sepsis and lower glucose level were significant predictors of mortality while, sepsis, pack year smoking, severe current exacerbation, SAPS II and lower pH were significant predictors of IMV need. The equations derived by combining these parameters are useful for identifying patients that are likely to have a poor outcome or need for IMV. However, due to the study limitations these findings should be validated by later larger studies.
